top of page


HKU and CEPI extend collaboration on development of COVID-19 nasal spray

19 Mar 2021

In response to the ongoing pandemic of COVID-19, the University of Hong Kong (HKU) has extended its collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) to evaluate a nasal spray COVID-19 vaccine made with live attenuated influenza viral vector. The effort is led by the State Key Laboratory for Emerging Infectious Diseases (SKL) at HKU. [...]

HKUMed found that robust SARS-CoV-2 infection in nasal turbinate underlies incomplete protection by systemic antibody or vaccine

4 Mar 2021

Researchers at the AIDS Institute, Department of Microbiology and State Key Laboratory of Emerging Infectious Diseases, LKS Faculty of Medicine of The University of Hong Kong (HKUMed), in collaboration with scientists at Tsinghua University and Columbia University, conducted a study for determining site-specific prevention of SARS-CoV-2 [...]

Thirteen HKU academics named amongst the world's most highly cited researchers in 2020

19 Nov 2020

Thirteen academics of the University of Hong Kong (HKU) have been named by Clarivate Analytics in its list of “2020 Highly Cited Researchers” as the most influential in the world. Their works have been highly cited by fellow academics and are hence making a significant impact in ongoing research in their respective fields of study. [...]

HKU’s COVID-19 vaccine candidate approved for human clinical trial

9 Sep 2020

The vaccine candidate against Covid-19 co-developed by HKU’s State Key Laboratory for Emerging Infectious Diseases (the SKL), has been approved by China’s National Medical Products Administration (NMPA) for human clinical trials. [...]

logo-removebg-preview (1).png


Tel: 3910 3688

Fax: 3753 2284


1. Laboratory: Unit 208-213, 2/F,  Building 15W, Hong Kong Science Park, Pak Shek Kok, N.T.

2. Office: Unit 313-316, 3/F, 
Building 17W, Hong Kong Science Park, Pak Shek Kok, N.T. 

  • 黑LinkedIn圖標
bottom of page